HLA-E and neoplasm: Its immunosuppressive effect is exerted from the interaction between NKG2A/CD94 and the non-classical HLA class I histocompatibility antigen, alpha chain E-(HLA-E) molecule overexpressed in these tumours, inhibiting the effector functions of CD8+ T and NK cells after phosphatase SHP-1 recruitment [42].